HealthPhoto: The HinduHealth Experts Say Cancer Drug Price Cuts Reveal Excessive Pricing
Health experts have stated that sharp reductions in cancer drug prices reveal excessive pricing in the market. The Supreme Court has highlighted gaps in maximum retail price (MRP) regulations, questioning the government's approach. While generics have become up to 93% cheaper, prices of 65 costly single-source cancer medicines remain unchanged, prompting calls for better regulation of medicine pricing.
The Hindu·




